Philipp Mohr

Philipp Mohr

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2024 in Frontiers in Nuclear Medicine
Verified
Journal Article
Open access
PDF file
PMPhilipp Mohr
Philipp Mohr
JSJoyce van Sluis
Joyce van Sluis
MHMarjolijn N. Lub-De Hooge
Marjolijn N. Lub-De Hooge
ALAdriaan A. Lammertsma
Adriaan A. Lammertsma
ABAdrienne H. Brouwers
Adrienne H. Brouwers
CTCharalampos Tsoumpas
Charalampos Tsoumpas
Immuno-positron emission tomography (immunoPET) enables imaging of specific targets that play a role in targeted therapy and immunotherapy, such as antigens on cell membranes, targets in the disease microenvironment, or immune cells. The most common immunoPET applications use a monoclonal antibody labeled with a relatively long-lived positron emitter such as 89Zr (T1/2 = 78.4 h), but smaller antibody-based constructs labeled with various other positron emitting radionuclides are also being investigated. This molecular imaging technique can thus guide the development of new drugs and may have a pivotal role in selecting patients for a particular therapy. In early phase immunoPET trials, multiple imaging time points are used to examine the time-dependent biodistribution and to determine the optimal imaging time point, which may be several days after tracer injection due to the slow kinetics of larger molecules. Once this has been established, usually only one static scan is performed and semi-quantitative values are reported. However, total PET uptake of a tracer is the sum of specific and nonspecific uptake. In addition, uptake may be affected by other factors such as perfusion, pre-/co-administration of the unlabeled molecule, and the treatment schedule. This article reviews imaging methodologies used in immunoPET studies and is divided into two parts. The first part summarizes the vast majority of clinical immunoPET studies applying semi-quantitative methodologies. The second part focuses on a handful of studies applying pharmacokinetic models and includes preclinical and simulation studies. Finally, the potential and challenges of immunoPET quantification methodologies are discussed within the context of the recent technological advancements provided by long axial field of view PET/CT scanners.

3 August 2023 in Journal of Nuclear Medicine
Verified
Journal Article
Closed access
PDF file
PMPhilipp Mohr
Philipp Mohr
JSJoyce van Sluis
Joyce van Sluis
LPLaura Providência
Laura Providência
JSJohannes H. van Snick
Johannes H. van Snick
MHMarjolijn N. Lub-De Hooge
Marjolijn N. Lub-De Hooge
CTCharalampos Tsoumpas
Charalampos Tsoumpas
The purpose of this study was to quantify any differences between the SUVs of 89Zr immuno-PET scans obtained using a PET/CT system with a long axial field of view (LAFOV; Biograph Vision Quadra) compared to a PET/CT system with a short axial field of view (SAFOV; Biograph Vision) and to evaluate how LAFOV PET scan duration affects image noise and SUV metrics. Methods: Five metastatic breast cancer patients were scanned consecutively on SAFOV and LAFOV PET/CT scanners. Four additional patients were scanned using only LAFOV PET/CT. Scans on both systems lasted approximately 30 min and were acquired 4 d after injection of 37 MBq of 89Zr-trastuzumab. LAFOV list-mode data were reprocessed to obtain images acquired using shorter scan durations (15, 10, 7.5, 5, and 3 min). Volumes of interest were placed in healthy tissues, and tumors were segmented semiautomatically to compare coefficients of variation and to perform Bland–Altman analysis on SUV metrics (SUVmax, SUVpeak, and SUVmean). Results: Using 30-min images, 2 commonly used lesion SUV metrics were higher for SAFOV than for LAFOV PET (SUVmax, 16.2% ± 13.4%, and SUVpeak, 10.1% ± 7.2%), whereas the SUVmean of healthy tissues showed minimal differences (0.7% ± 5.8%). Coefficients of variation in the liver derived from 30-min SAFOV PET were between those of 3- and 5-min LAFOV PET. The smallest SUVmax and SUVpeak differences between SAFOV and LAFOV were found for 3-min LAFOV PET. Conclusion: LAFOV 89Zr immuno-PET showed a lower SUVmax and SUVpeak than SAFOV because of lower image noise. LAFOV PET scan duration may be reduced at the expense of increasing image noise and bias in SUV metrics. Nevertheless, SUVpeak showed only minimal bias when reducing scan duration from 30 to 10 min. Visual Abstract

14 January 2026 in Physics in Medicine & Biology
Verified
Journal Article
Open access
DSDavid Sarrut
David Sarrut
NANicolas Arbor
Nicolas Arbor
TBThomas Baudier
Thomas Baudier
JBJulien Bert
Julien Bert
Konstantinos ChatzipapasKonstantinos Chatzipapas
Konstantinos Chatzipapas
NKNils Krah
Nils Krah
We present GATE version 10, a major evolution of the open-source Monte Carlo simulation application for medical physics, built on Geant4. This release marks a transformative evolution, featuring a modern Python-based user interface, enhanced multithreading and multiprocessing capabilities, the ability to be embedded as a library within other software, and a streamlined framework for collaborative development. In this Part 1 paper, we outline GATE’s position among other Monte Carlo codes, the core principles driving this evolution, and the robust development cycle employed. We also detail the new features and improvements. Part 2 will focus on the architectural innovations and technical challenges. By combining an open, collaborative framework with cutting-edge features, such a Monte Carlo platform supports a wide range of academic and industrial research, solidifying its role as a critical tool for innovation in medical physics.

27 October 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MRMostafa Roya
Mostafa Roya
SMSamaneh Mostafapour
Samaneh Mostafapour
PMPhilipp Mohr
Philipp Mohr
LPLaura Providência
Laura Providência
ZLZekai Li
Zekai Li
Joyce van SluisJoyce van Sluis
Joyce van Sluis
The latest technical development in the field of positron emission tomography/computed tomography (PET/CT) imaging has been the extension of the PET axial field-of-view. As a result of the increased number of detectors, the long axial field-of-view (LAFOV) PET systems are not only characterized by a larger anatomical coverage but also by a substantially improved sensitivity, compared with conventional short axial field-of-view PET systems. In clinical practice, this innovation has led to the following optimization: (1) improved overall image quality, (2) decreased duration of PET examinations, (3) decreased amount of radioactivity administered to the patient, or (4) a combination of any of the above. In this review, novel applications of LAFOV PET in oncology are highlighted and future directions are discussed.

22 September 2022 in IEEE Transactions on Radiation and Plasma Medical Sciences
Verified
Journal Article
Open access
PMPhilipp Mohr
Philipp Mohr
NENikos Efthimiou
Nikos Efthimiou
FPFiammetta Pagano
Fiammetta Pagano
NKNicolaus Kratochwil
Nicolaus Kratochwil
MPMarco Pizzichemi
Marco Pizzichemi
KZKarl Ziemons
Karl Ziemons
The concept of structure engineering has been proposed for exploring the next generation of radiation detectors with improved performance. A TOF-PET geometry with heterostructured scintillators with a pixel size of $3.0 \times 3.1 \times 15\,\,\mathrm {mm^{3}}$ was simulated using Monte Carlo. The heterostructures consisted of alternating layers of BGO as a dense material with high stopping power and plastic (EJ232) as a fast light emitter. The detector time resolution was calculated as a function of the deposited and shared energy in both materials on an event-by-event basis. While sensitivity was reduced to 32% for 100- $\mu \text{m}$ thick plastic layers and 52% for $50~\mathrm {\mu m}$ , the coincidence time resolution (CTR) distribution improved to 204 ± 49 and 220±41 ps, respectively, compared to 276 ps that we considered for bulk BGO. The complex distribution of timing resolutions was accounted for in the reconstruction. We divided the events into three groups based on their CTR and modeled them with different Gaussian TOF kernels. On an NEMA IQ phantom, the heterostructures had better contrast recovery in early iterations. On the other hand, BGO achieved a better contrast-to-noise ratio (CNR) after the 15th iteration due to the higher sensitivity. The developed simulation and reconstruction methods constitute new tools for evaluating different detector designs with complex time responses.

14 January 2026 in Physics in Medicine & Biology
Verified
Journal Article
Open access
NKNils Krah
Nils Krah
NANicolas Arbor
Nicolas Arbor
TBThomas Baudier
Thomas Baudier
JBJulien Bert
Julien Bert
Konstantinos ChatzipapasKonstantinos Chatzipapas
Konstantinos Chatzipapas
DSDavid Sarrut
David Sarrut
Over the past years, we have developed GATE version 10, a major re-implementation of the long-standing Geant4-based Monte Carlo application for particle and radiation transport simulation in medical physics. This release introduces many new features and significant improvements, most notably a Python-based user interface replacing the legacy static input files. The new functionality of GATE version 10 is described in the part 1 companion paper (Sarrut et al 2025 arXiv:2507.09842). The development brought significant challenges. In this paper, we present the solutions that we have developed to overcome these challenges. In particular, we present a modular design that robustly manages the core components of a simulation: particle sources, geometry, physics processes, and data acquisition. The architecture consists of integrated C++ and Python codes. This framework allows for the precise, time-aware generation of primary particles, a critical requirement for accurately modeling positron emission tomography, radionuclide therapies, or prompt-gamma timing systems. We present how GATE 10 handles complex Geant4 physics settings while exposing a simple interface to the user. Furthermore, we describe the methodological solutions that facilitate the seamless integration of advanced physics models and variance reduction techniques. The architecture supports sophisticated scoring of physical quantities (such as Linear Energy Transfer and Relative Biological Effectiveness) and is designed for multithreaded execution. The new user interface allows researchers to script complex simulation workflows and directly couple external tools, such as artificial intelligence models for source generation or detector response. By detailing these architectural innovations, we demonstrate how GATE 10 provides a more powerful and flexible tool for research and innovation in medical physics. This paper is not intended to be a developer guide. Its purpose is to share with the research community in-depth explanations of our development effort that made the new GATE 10 possible.